• Publications
  • Influence
Pulmonary complications of infective endocarditis in intravenous drug users
Pulmonary manifestations of infective endocarditis (IE) in intravenous drug users may resemble variety of diseases and result from systemic effects of infection, metastatic foci and emboli. TheExpand
  • 2
[Kidney involvement in infectious endocarditis (hematuria)].
As many as 113 patients suffering from infectious endocarditis (IE) were placed under observation. Renal damage was discovered in 28 patients (24.7%). Hematuria was the common laboratory sign ofExpand
  • 3
[Ceftriaxone in the treatment of staphylococcal endocarditis].
Efficacy and safety of ceftriaxone (Oframax, Ranbaxy, India) in the treatment of 25 patients with Staphylococcus endocarditis (SE) were studied. The drug was administered intravenously in a dose ofExpand
  • 1
[Management of patients with infectious endocarditis].
The paper presents clinical manifestations of infectious endocarditis (IE), its new clinical classification, diagnostic criteria, potentialities and limitations of echocardiography. GeneralExpand
  • 2
[Myocardial infarction in patients with infectious endocarditis].
Myocardial infarction (MI) developed in 9% of 230 patients with active infectious endocarditis. Development of MI was associated with worsened clinical course and poorer prognosis of infectiousExpand
  • 1
Effects of levamisole on the phagocytic function of polymorphonuclear neutrophils from patients with systemic lupus erythematosus.
Incubation of polymorphonuclear (PMN) cells from patients with systemic lupus erythematosus (SLE) with levamisole increased the ability of those cells to reduce nitroblue tetrazolium (NBT). PMN cellsExpand
  • 1
[Bacterial endocarditis: its current course and diagnosis].
Investigations have shown that the etiology of bacterial endocarditis (BE) has notably changed, with the prevalence of highly virulent agents which alter a course of disease and often determine aExpand